Shares of Illumina Inc. ILMN rose 2.33% to $86.62 Friday, on what proved to be an all-around positive trading session for the ...

What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.

Illumina stock slid on Tuesday after China banned imports of the biotech’s gene sequencing machines as part of a broader ...

Illumina stock skidded Tuesday after China signaled it would ban the company from importing its gene-mapping products.

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Competitive Landscape: Illumina faces increasing competition from companies like Pacific Biosciences ... appears on our undervalued or overvalued stock lists. These tools provide a clearer ...

Illumina faces a new challenge as China has prohibited the import of the company’s sequencers ... foresee continued pressure on the stock, highlighting competition from Roche’s new SBX ...

Illumina faces a new challenge as China has prohibited the import of the company’s sequencers ... Meanwhile, Citi analysts foresee continued pressure on the stock, highlighting competition from Roche ...

China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...

Competitive Landscape: Illumina faces increasing competition from companies like Pacific Biosciences (NASDAQ ... You can also see if ILMN appears on our undervalued or overvalued stock lists. These ...

Gene-sequencing giant Illumina is laying ... increased competition and a declining stock price, which is down about 35% year to date. The company announced the layoffs last month in a WARN ...